EUVIMEDEUVIMED entdecken
Crossref

Tracking the turning point in Alzheimer’s disease

Bart De Strooper, Henrik Zetterberg

Science · 30.04.2026 · 392 (6797) · 468-469

DOI: 10.1126/science.aeb6987 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, erschienen am 30.04.2026. Verfasst von Bart De Strooper und 1 weiteren Autor:innen. Beteiligte Einrichtung: Leuven Brain Institute, University of Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, tau Proteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A blood biomarker reveals the mechanistic shift from amyloid to tau pathology

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAmyloid beta-Peptidestau ProteinsHumansBiomarkers

Substanzen

Amyloid beta-PeptidesBiomarkerstau Proteins

Autor:innen und Institutionen

  • Leuven Brain Institute, University of Leuven, Leuven, Belgium.
  • Center for Brain and Disease Research, VIB, Leuven, Belgium.
  • UK Dementia Research Institute, University College London, London, UK.
  • Department of Psychiatry and Neurochemistry, University of Gothenburg, Gothenburg, Sweden.
  • Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA.

Zitieren

APA

De Strooper, B., & Zetterberg, H. (2026). Tracking the turning point in Alzheimer’s disease. Science, 392(6797), 468-469. https://doi.org/10.1126/science.aeb6987

Vancouver

De Strooper B, Zetterberg H. Tracking the turning point in Alzheimer’s disease. Science. 2026;392(6797):468-469. doi:10.1126/science.aeb6987

BibTeX
@article{DeStrooper2026,
  author = {De Strooper, Bart and Zetterberg, Henrik},
  title = {Tracking the turning point in Alzheimer’s disease},
  journal = {Science},
  year = {2026},
  volume = {392},
  number = {6797},
  pages = {468--469},
  doi = {10.1126/science.aeb6987}
}
Kostenlos starten →